Interní Med. 2009; 11(1): 21-24

The elderly patient with chronic renal insufficiency

prof. MUDr. Václav MONHART CSc1,2
1 III. interní oddělení, Ústřední vojenská nemocnice Praha
2 Interní klinika 1. LF UK a ÚVN, KlinLab s. r. o., Praha

Diabetic nephropathy, hypertonic and atherosclerotic kidney injury, chronic glomerulonephritis, chronic intersticial nephritis and

obstructive uropathy represent the most frequent causation of chronic renal insufficiency in elderly patients. The risk factors for high

incidence of chronic kidney diseases are aging of population, increasing numbers of diabetes mellitus, obesity and hypertension. The topical

problem of vast bulk of chronic kidney diseases is progression to end-stage renal disease and increased cardiovascular morbidity.

The goal of treatment is to modify classical and renal specific risk factors for cardiovascular disease. The most important measures for

both delaying or avoiding end-stage renal disease and reduction in risk of cardiovascular complications are blood pressure control

(< 130/80 mm Hg) and decrease in proteinuria.

Keywords: Key words: chronic renal insufficiency, diabetic nephropathy, hypertensive nephropathy, ischemic nephropathy.

Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
MONHART V. The elderly patient with chronic renal insufficiency. Interní Med. 2009;11(1):21-24.
Download citation

References

  1. Jabor A, Hornová L, Fantová L, Engliš M. Vyšetření funkce ledvin: možnosti biochemické laboratoře. Postgrad Med 2006; 9: 18-23.
  2. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Am Intern Med 1999; 130: 461-470. Go to original source... Go to PubMed...
  3. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12. Go to original source... Go to PubMed...
  4. De Zeeuw D, Hillege HL, de Jong PE. The kidney, a cardiovascular risk marker and a new target for therapy. Kidney Int 2005; Suppl 98: 25-29. Go to original source... Go to PubMed...
  5. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease. Evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147. Go to original source... Go to PubMed...
  6. Fox CS, Larson MG, Leip EP, et al. Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291: 844-850. Go to original source... Go to PubMed...
  7. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: Estimations for the zdar 2000 and projection for 2030. Diabetes Care 2004; 27: 1047-1053. Go to original source... Go to PubMed...
  8. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-223. Go to original source...
  9. Hollenberg NK. Obesity and the kidney: Why is the kidney at risk? Kidney Int 2007; 71: 187-188. Go to original source... Go to PubMed...
  10. Yamagata K, Ishida K, Sairenchi T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int 2007; 71: 159-166. Go to original source... Go to PubMed...
  11. Gomez P, Ruilope LM, Barrios V, et al. Prevalence of renal insufficiency in individuals with hypertension and obesity/overweight: The FATH Study. J Am Soc Nephrol 2006; 17 (Suppl 3): S194-200. Go to original source... Go to PubMed...
  12. Rychlík I, Tesař V. a kol. Onemocnění ledvin u diabetes mellitus. Horizonty diabetologie, díl 2; Praha: Tigis 2005: 150-161.
  13. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertension 2007; 25: 1105-1187. Go to original source... Go to PubMed...
  14. Monhart V. Hypertenze a ledviny. 2. rozšířené a přepracované vydání. Praha: Triton 2007. 207 s.
  15. Horáčková M. Ischemická choroba ledvin. In: Teplan V a kol. Praktická nefrologie. 2., zcela přepracované a doplněné vydání. Praha: Grada, 2006, s. 199-210.
  16. Ryšavá R. Cévní onemocnění ledvin. In: Tesař V, Schuck O a kol. Klinická nefrologie. Praha: Grada 2006, 297-309.
  17. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular diasease. AHA Scientific Statement. Circulation 2003; 108: 2154-2169. Go to original source... Go to PubMed...
  18. Henry RMA, Kostense PJ, Bos G, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int 2002; 62: 1402-1407. Go to original source... Go to PubMed...
  19. Keith D, Nicholls G, Guillion C, et al. Longitudinal followup and outcomes among a population with chronic kidney disease in a large managed care organisation. Arch Intern Med 2004; 164: 659-663. Go to original source... Go to PubMed...
  20. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007; 49 (2 Suppl 2): S1-S179.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.